Washington D.C. Council Bill 210032 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 3-0)
Status: Engrossed on December 6 2016 - 50% progression, died in chamber
Action: 2016-12-20 - Final Reading CC
Text: Latest bill text (Engrossed) [PDF]

As introduced, this bill imposes a limit on the amount that a person must pay, in copayment or coinsurance, through a health benefit plan, for a prescription for a specialty drug. The copayment shall not exceed $150 per month for up to a 30-day supply of the specialty drug. A specialty drug includes a prescription drug prescribed for a condition that may have no known cure, is progressive, or can be debilitating or fatal if left untreated, and affects fewer than 200,000 persons in the United States. It also provides that a health benefit plan or its representative may request that a non-preferred drug be covered under the cost sharing applicable for preferred drugs if the prescribing physician determines that the preferred drug, available for treatment of the same condition, either would not be as effective for the individual or would have adverse effects for the individual. Non-preferred drugs are specialty drug formulary classifications that are subject to limits on eligibility for coverage or subject to higher cost-sharing amounts than preferred specialty drugs.

Specialty Drug Copayment Limitation Act Of 2015

Cnc. Mary Cheh [D]

Cnc. Anita Bonds [D]

Cnc. Charles Allen [D]

2016-12-20 - Council - Final Reading CC (Y: 13 N: 0 NV: 0 Abs: 0) [PASS]
2016-12-06 - Council - First Reading CC (Y: 13 N: 0 NV: 0 Abs: 0) [PASS]

Date	Chamber	Action
2016-12-20	Council	Final Reading CC
2016-12-08	Council	Committee Report Filed
2016-12-06	Council	Committee Mark-up of B21-0032
2016-12-06	Council	First Reading CC
2016-11-21	Council	Committee Report Filed
2016-11-16	Council	Committee Mark-up of B21-0032
2015-10-28	Council	Public Hearing Held
2015-09-11	Council	Notice of Public Hearing Published in the DC Register
2015-01-30	Council	Notice of Intent to Act on B21-0032 Published in the DC Register
2015-01-20	Council	Referred to Committee on Business, Consumer, and Regulatory Affairs
2015-01-20	Council	Introduced in Committee of the Whole

Type	Source
Summary	http://lims.dccouncil.gov/Legislation/B21-0032
Text	http://lims.dccouncil.gov/_layouts/15/uploader/download.aspx?legislationid=33255&filename=B21-0032-Introduction.pdf
Text	http://lims.dccouncil.gov/Download/33255/B21-0032-Engrossment.pdf
Roll Call	http://lims.dccouncil.gov/Legislation/B21-0032